- Home
- KYN vs APLS Comparison
KYN vs APLS Comparison
Compare KYN & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYN
- APLS
- Stock Information
- Founded
- KYN 2004
- APLS 2009
- Country
- KYN United States
- APLS United States
- Employees
- KYN N/A
- APLS N/A
- Industry
- KYN Finance/Investors Services
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- KYN Finance
- APLS Health Care
- Exchange
- KYN Nasdaq
- APLS Nasdaq
- Market Cap
- KYN 2.0B
- APLS 2.3B
- IPO Year
- KYN N/A
- APLS 2017
- Fundamental
- Price
- KYN $12.15
- APLS $17.30
- Analyst Decision
- KYN
- APLS Buy
- Analyst Count
- KYN 0
- APLS 19
- Target Price
- KYN N/A
- APLS $39.06
- AVG Volume (30 Days)
- KYN 561.5K
- APLS 2.8M
- Earning Date
- KYN 01-01-0001
- APLS 05-07-2025
- Dividend Yield
- KYN 8.99%
- APLS N/A
- EPS Growth
- KYN N/A
- APLS N/A
- EPS
- KYN 0.71
- APLS N/A
- Revenue
- KYN N/A
- APLS $775,839,000.00
- Revenue This Year
- KYN N/A
- APLS $12.25
- Revenue Next Year
- KYN N/A
- APLS $21.08
- P/E Ratio
- KYN $13.79
- APLS N/A
- Revenue Growth
- KYN N/A
- APLS 48.04
- 52 Week Low
- KYN $7.84
- APLS $16.65
- 52 Week High
- KYN $9.88
- APLS $43.99
- Technical
- Relative Strength Index (RSI)
- KYN 55.45
- APLS 34.14
- Support Level
- KYN $11.67
- APLS $16.65
- Resistance Level
- KYN $12.04
- APLS $20.75
- Average True Range (ATR)
- KYN 0.25
- APLS 1.09
- MACD
- KYN 0.07
- APLS 0.14
- Stochastic Oscillator
- KYN 92.86
- APLS 15.85
About KYN Kayne Anderson Energy Infrastructure Fund Inc.
Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.